Amryt Pharma (Amryt Pharma) FCF Yield % : 10.94 (As of May. 19, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Amryt Pharma FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Amryt Pharma's Trailing 12-Month Free Cash Flow is $0.0 Mil, and Market Cap is $942.8 Mil. Therefore, Amryt Pharma's FCF Yield % for today is 10.94%.

The historical rank and industry rank for Amryt Pharma's FCF Yield % or its related term are showing as below:

AMYT' s FCF Yield % Range Over the Past 10 Years
Min: 0 Med: 0 Max: 10.94
Current: 10.94

During the past 12 years, the highest FCF Yield % of Amryt Pharma was 10.94%. The lowest was 0.00%. And the median was 0.00%.

AMYT's FCF Yield % is not ranked
in the Drug Manufacturers industry.
Industry Median: -0.49 vs AMYT: 10.94

Amryt Pharma's FCF Margin % for the quarter that ended in Sep. 2022 was 22.91%.

Amryt Pharma FCF Yield % Historical Data

The historical data trend for Amryt Pharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amryt Pharma FCF Yield % Chart

Amryt Pharma Annual Data

Trend

Mar12

Mar13

Mar14

Mar15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

FCF Yield %

Get a 7-Day Free Trial

-15.69

4.82

2.03

Amryt Pharma Quarterly Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
FCF Yield %	Get a 7-Day Free Trial															-65.21	61.85	-6.01	-5.53	12.65

Competitive Comparison of Amryt Pharma's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Amryt Pharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Amryt Pharma's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amryt Pharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Amryt Pharma's FCF Yield % falls into.

Amryt Pharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Amryt Pharma's FCF Yield % for the fiscal year that ended in Dec. 2021 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	13.995	/	690.8004
	=	2.03%

Amryt Pharma's annualized FCF Yield % for the quarter that ended in Sep. 2022 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	14.004	*	4	/	442.684164
	=	12.65%

Amryt Pharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Amryt Pharma FCF Yield % Related Terms

Thank you for viewing the detailed overview of Amryt Pharma's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Amryt Pharma (Amryt Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amryt Pharma PLC (NAS:AMYT) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

196 High Road, Dept 920A, Wood Green, London, GBR, N22 8HH

Website

http://www.amrytpharma.com

Amryt Pharma PLC is a specialty pharmaceutical company. It is focused on developing and delivering new treatments to help improve the lives of patients with rare or orphan diseases. It holds an exclusive license to sell Lojuxta (lomitapide) for adults, across the European Union and other territories including the Middle East, North Africa, Turkey and Israel. Lojuxta is used to treat a rare life-threatening disease called Homozygous Familial Hypercholesterolemia. Myalept (metreleptin) is an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients. It derives most of the revenue from the European Economic Area (EEA).